Moderna Tumbles On Report Of Delayed COVID Vaccine Trial

Moderna shares are down 7% following headlines that its virus vaccine trial has been delayed...

MRNA back to its lowest since May...

Where's Dr. Fauci to tell us how great it is still?

Interestingly, this headline hit shortly after WHO's Chief Scientist Soumya Swaminathan said that more analysis was need to understand the efficacy of Gilead's Remdesivir.